Catalyst Wire Dossier Catalyst Wire Dossier

Squalamine ophthalmic solution

squalamine · Ohr Pharmaceutical Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Squalamine ophthalmic solution, covering 2017-04-27 to 2017-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD [Phase 3]

See pricing